<DOC>
	<DOCNO>NCT00045331</DOCNO>
	<brief_summary>RATIONALE : Proteins find blood urine sample may help predict outcome allow doctor plan effective treatment . PURPOSE : Diagnostic trial study blood urine proteins predict treatment outcome patient undergo radiation therapy prostate cancer .</brief_summary>
	<brief_title>Study Predicting Outcome Patients Undergoing Radiation Therapy Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Correlate serum urine protein profile collect radiotherapy clinical outcome patient prostate cancer . - Identify protein profile distinguish patient evidence disease biochemical and/or clinical failure . - Determine whether serum proteomic profile consistent failure identify early time point course treatment follow-up patient . OUTLINE : Patients stratify accord clinical outcome ( prior radiotherapy v evidence disease vs biochemical failure v clinical failure vs clinical outcome yet determine ) . Urine blood specimen collect patient either definitive radiotherapy . Samples analyze surface-enhanced laser desorption ionization time-of-flight mass spectrometry develop proteomic pattern . Results proteomic profile influence patient care . PROJECTED ACCRUAL : A total 150 patient ( 30 per stratum ) accrue study .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm prostate cancer Completed plan definitive radiotherapy PATIENT CHARACTERISTICS : Age Adult Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify PRIOR CONCURRENT THERAPY : Biologic therapy Concurrent immunotherapy allow Chemotherapy Concurrent chemotherapy allow Endocrine therapy Concurrent hormonal therapy allow Radiotherapy See Disease Characteristics Concurrent palliative radiotherapy allow Surgery No prior prostatectomy , include radical prostatectomy No concurrent radical prostatectomy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2004</verification_date>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
</DOC>